IQVIA Holdings Inc. (IQV)
NYSE: IQV · Real-Time Price · USD
178.81
+8.17 (4.79%)
At close: Feb 27, 2026, 4:00 PM EST
179.03
+0.22 (0.12%)
After-hours: Feb 27, 2026, 7:03 PM EST
IQVIA Holdings Revenue
In the year 2025, IQVIA Holdings had annual revenue of $16.31B with 5.87% growth. IQVIA Holdings had revenue of $4.36B in the quarter ending December 31, 2025, with 10.26% growth.
Revenue (ttm)
$16.31B
Revenue Growth
+5.87%
P/S Ratio
1.86
Revenue / Employee
$175,376
Employees
93,000
Market Cap
30.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.31B | 905.00M | 5.87% |
| Dec 31, 2024 | 15.41B | 421.00M | 2.81% |
| Dec 31, 2023 | 14.98B | 574.00M | 3.98% |
| Dec 31, 2022 | 14.41B | 536.00M | 3.86% |
| Dec 31, 2021 | 13.87B | 2.52B | 22.14% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Labcorp Holdings | 13.95B |
| Quest Diagnostics | 11.04B |
| Agilent Technologies | 7.07B |
| Illumina | 4.34B |
| IDEXX Laboratories | 4.30B |
| Mettler-Toledo International | 4.03B |
| Exact Sciences | 3.25B |
| Waters | 3.17B |
IQV News
- 11 hours ago - IQVIA Holdings: Still Exceeding Expectations As A Stealth Compounder - Seeking Alpha
- 1 day ago - IQVIA Releases its 2025 Sustainability Report - Business Wire
- 2 days ago - IQVIA Holdings Inc. (IQV) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript - Seeking Alpha
- 3 days ago - IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities - Business Wire
- 4 days ago - 10 stocks Wall Street expects to roar back after dropping at least 20% in 2026 - Market Watch
- 10 days ago - IQVIA to Speak at Citi's 2026 Unplugged MedTech and Life Sciences Access Day - Business Wire
- 16 days ago - Oakmark Global All Cap Strategy Q4 2025 Performance Review - Seeking Alpha
- 18 days ago - IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions - Business Wire